Aug 07, 2025 Posted on 7 August 20257 August 2025 Teva’s Ajovy becomes first migraine prevention drug approved for children
Aug 22, 2024 Posted on 22 August 202410 October 2024 Bayer and MOMA Therapeutics partner for oncology programme
Jul 12, 2024 Posted on 12 July 20244 October 2024 Teva and mAbxience partner to develop biosimilar candidate for oncology
